168 related articles for article (PubMed ID: 11708830)
1. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
[TBL] [Abstract][Full Text] [Related]
2. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
3. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
4. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
5. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
6. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
Moore KJ; Labrecque S; Matlashewski G
J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
[TBL] [Abstract][Full Text] [Related]
7. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
Melby PC; Yang YZ; Cheng J; Zhao W
Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
Reiner NE; Finke JH
J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
[TBL] [Abstract][Full Text] [Related]
11. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
Olivier M; Proulx C; Tanner CE
J Parasitol; 1989 Oct; 75(5):720-7. PubMed ID: 2529362
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Murray HW; Masur H; Keithly JS
J Immunol; 1982 Jul; 129(1):344-50. PubMed ID: 7086136
[No Abstract] [Full Text] [Related]
13. Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
Smelt SC; Engwerda CR; McCrossen M; Kaye PM
J Immunol; 1997 Apr; 158(8):3813-21. PubMed ID: 9103448
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of lymphoid organs in experimental leishmaniasis.
Corbett CE; Paes RA; Laurenti MD; Andrade Júnior HF; Duarte MI
Int J Exp Pathol; 1992 Aug; 73(4):417-33. PubMed ID: 1390190
[TBL] [Abstract][Full Text] [Related]
15. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
16. Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani.
Evans TG; Smith D; Pearson RD
J Parasitol; 1990 Apr; 76(2):212-7. PubMed ID: 2319422
[TBL] [Abstract][Full Text] [Related]
17. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice.
Hockertz S; Baccarini M; Lohmann-Matthes ML
J Immunol; 1989 Apr; 142(7):2489-94. PubMed ID: 2926141
[TBL] [Abstract][Full Text] [Related]
18. [Observation on susceptibilities and immune responses of four strains of mice to the infection of a Leishmania donovani Chinese strain].
Yi TL; Hu XS; Feng RY
Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):122-6. PubMed ID: 3837361
[No Abstract] [Full Text] [Related]
19. Immunostimulant activity of Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters.
Puri A; Saxena RP; Sumati ; Guru PY; Kulshreshtha DK; Saxena KC; Dhawan BN
Planta Med; 1992 Dec; 58(6):528-32. PubMed ID: 1484891
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.
Kaye PM
Immunology; 1987 Jul; 61(3):345-9. PubMed ID: 3111982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
